|
|
|
|
 
|
|
Small pharmaceutical and biotech companies utilize various strategies to develop their discoveries. Some prefer to license their product
to a larger pharmaceutical company; others prefer to maintain a hand in the drug development process by securing sufficient venture capital
to fund critical clinical testing.
Best Practice helps clients present their discoveries to a venture capital firm or for licensure to a large pharmaceutical company.
Specifically, we help our clients:
|
|
 |
create scientifically sound and operationally practical product development plans |
|
|
identify sources of funding to develop their new product |
|
|
persuade venture capitalists of the potential clinical utility of the product |
Best Practice can also assist venture capital firms in their due diligence assessments of potential products and of small companies. We
provide "scientific due diligence," which strengthens our clients' ability to evaluate new discoveries, leading to wiser investments
decisions. Best Practice offers our venture capital clients:
|
|
scientific review and advice on preclinical data of CNS products and pipeline drugs |
|
|
expert clinical opinion leadership on the therapeutic application and potential clinical market of these products and pipeline drugs |
|
|
|
|
|
Copyright Best Practice Project Management, Inc. All rights reserved. Privacy Statement |
|
|
